189 related articles for article (PubMed ID: 32770964)
1. VEGF, apelin and HO-1 in diabetic patients with retinopathy: a correlation analysis.
Wu R; Zhu Z; Zhou D
BMC Ophthalmol; 2020 Aug; 20(1):326. PubMed ID: 32770964
[TBL] [Abstract][Full Text] [Related]
2. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
3. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
4. Highly-Expressed MiR-221-3p Distinctly Increases the Incidence of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
Zhao L; Pan Q
Transl Vis Sci Technol; 2023 Oct; 12(10):17. PubMed ID: 37856104
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients.
Du JH; Li X; Li R; Xu L; Ma RR; Liu SF; Zhang Z; Sun HZ
Int J Ophthalmol; 2014; 7(6):968-73. PubMed ID: 25540748
[TBL] [Abstract][Full Text] [Related]
6. Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy.
Zhou ZW; Ju HX; Sun MZ; Fu QP; Chen HM; Ji HB; Ji F; Jiang DM
Clin Chim Acta; 2016 Apr; 455():113-7. PubMed ID: 26851648
[TBL] [Abstract][Full Text] [Related]
7. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.
You QY; Zhuge FY; Zhu QQ; Si XW
Int J Ophthalmol; 2014; 7(4):648-53. PubMed ID: 25161936
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
9. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device.
Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L
Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy.
Ahuja S; Saxena S; Akduman L; Meyer CH; Kruzliak P; Khanna VK
Int J Retina Vitreous; 2019; 5():29. PubMed ID: 31583119
[TBL] [Abstract][Full Text] [Related]
11. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H
Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840
[TBL] [Abstract][Full Text] [Related]
12. The changing features of serum adropin, copeptin, neprilysin and chitotriosidase which are associated with vascular endothelial function in type 2 diabetic retinopathy patients.
Li B; Li N; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
J Diabetes Complications; 2020 Nov; 34(11):107686. PubMed ID: 32768333
[TBL] [Abstract][Full Text] [Related]
13. Serum Vascular Endothelial Growth Factor Levels Correlate with Severity of Retinopathy in Diabetic Patients: A Systematic Review and Meta-Analysis.
Zhou Z; Ju H; Sun M; Chen H
Dis Markers; 2019; 2019():9401628. PubMed ID: 31019585
[TBL] [Abstract][Full Text] [Related]
14. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.
Mohan A; Saxena S; Kaur A; Ali W; Akduman L
Mol Vis; 2021; 27():429-437. PubMed ID: 34267498
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum delta-like ligand-4 level with the severity of diabetic retinopathy.
Zhu Y; Hu J; Du X; Fang Q; Zhou Y; Chen K
BMC Endocr Disord; 2021 Aug; 21(1):157. PubMed ID: 34362349
[TBL] [Abstract][Full Text] [Related]
16. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy.
Bonfiglio V; Platania CBM; Lazzara F; Conti F; Pizzo C; Reibaldi M; Russo A; Fallico M; Ortisi E; Pignatelli F; Longo A; Avitabile T; Drago F; Bucolo C
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334029
[TBL] [Abstract][Full Text] [Related]
17. Serum Ang-1/Ang-2 ratio may be a promising biomarker for evaluating severity of diabetic retinopathy.
Wang Y; Fang J; Niu T; Xing X; Wang H; Shi X; Liu Y; Liu X; Chen C; Liu K
Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):49-55. PubMed ID: 35838805
[TBL] [Abstract][Full Text] [Related]
18. Plasma
Jiang Q; Lyu XM; Yuan Y; Wang L
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
[TBL] [Abstract][Full Text] [Related]
19. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
[TBL] [Abstract][Full Text] [Related]
20. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus.
Ding Y; Ge Q; Qu H; Feng Z; Long J; Wei Q; Zhou Q; Wu R; Yao L; Deng H
J Endocrinol Invest; 2018 Aug; 41(8):937-945. PubMed ID: 29349642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
